-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.88117.03% Upside
Atea Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Atea Pharmaceuticals, Inc.?
Atea Pharmaceuticals, Inc. has been rated by research analysts at Morgan Stanley in the past 90 days.